Radioembolization after portal vein embolization in a patient with multifocal hepatocellular carcinoma

CardioVascular and Interventional Radiology

Volumn 35, Issue 6, 2012, Pages 1519-1523

  Burgmans, Mark C ^a   Irani, Farah G ^a   Chan, Wan Ying ^a   Teo, Terence K ^a   Kao, Yung Hsiang ^a   Goh, Anthony S W ^a   Chow, Pierce K ^a,b,c   Lo, Richard H ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Hepatocellular carcinoma; Portal vein embolization; Radioembolization

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; YTTRIUM 90; POLYVINYL ALCOHOL; TUMOR MARKER;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HEPATOGRAPHY; HUMAN; LIVER CELL CARCINOMA; MALE; MULTIPLE CANCER; PATIENT SAFETY; PORTAL VEIN EMBOLIZATION; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIOEMBOLIZATION; RADIOFREQUENCY ABLATION; THERAPY EFFECT; BLOOD; COMPUTER ASSISTED DIAGNOSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; LIVER FUNCTION TEST; LIVER TUMOR; METHODOLOGY; PORTAL VEIN; RADIOGRAPHY;

AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; POLYVINYL ALCOHOL; PORTAL VEIN; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 84878215149     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0376-2     Document Type: Article

References (11)

1. Raoul JL, Sangro B, Forner A et al (2011) Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev 37(3):212-220
2. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37(2):429-442
3. Sangro B, Salem R, Kennedy A et al (2011) Radioembolization for hepatocellular carcinoma: a review of the evidence and treatment recommendations. Am J Clin Oncol 34(4):422-443
4. Sato K, Lewandowski RJ, Bui JT et al (2006) Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol 29(4):522-529
5. Iñarrairaegui M, Thurston KG, Bilbao JI et al (2010) Radioembolization with use of Yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 21:1205-1212
6. Tsai AL, Burke CT, Kennedy AS et al (2010) Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 21(9):1377-1384
7. Omata M, Lesmana LA, Tateishi R et al (2010) Asian Pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439-474
8. Madoff DC, Hicks ME, Vauthey JN et al (2002) Transhepatic portal vein embolization: anatomy, indications, and technical considerations. RadioGraphics 22:1063-1076
9. Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52-60
10. Abulkhir A, Limongelli P, Haeley AJ et al (2008) Preoperative portal vein embolization for major live resection: a meta analysis. Ann Surg 247(1):49-57
11. de Graaf W, van den Esschert JW, van Lienden KP et al (2009) Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol 16:423-430